Yas Clinic Khalifa City and Abu Dhabi Stem Cells Center (ADSCC) have entered into a memorandum of understanding (MoU) with Ohio University to advance research and innovation in cell and gene therapy, supporting the growth of Abu Dhabi’s knowledge-based healthcare economy.
The agreement was unveiled during a dedicated scientific exchange event in Abu Dhabi, bringing together senior clinicians, researchers, and global experts to explore the future of stem cell innovation and advanced cellular therapies.
Discussions focused on cutting-edge developments in cell and gene therapy, including applications extending beyond oncology into broader areas of regenerative and precision medicine.
The partnership aims to enhance research cooperation, facilitate knowledge exchange, and support the development of innovative therapies in hematology, oncology, and regenerative medicine. By integrating academic research with clinical expertise, the collaboration seeks to accelerate the translation of scientific discoveries into practical treatments that improve patient outcomes.
Dr. Maysoon Al Karam Chief Medical Officer Yas Clinic – Khalifa City
“This collaboration reflects our dedication to strengthening our academic ecosystem and expanding innovation in cell and gene therapy. Working alongside ADSCC and Ohio University enables us to translate research into advanced therapies that will benefit patients and future generations.”
The scientific exchange program highlighted global progress in CAR-T therapy and other advanced cellular treatments, emphasizing the importance of coordinated research efforts and local clinical application to accelerate therapeutic development.
Mubasher Maqbul, Acting CEO of Yas Clinic, remarked that, “By collaborating closely with Ohio University and ADSCC, we are creating new pathways for scientific discovery that will enhance patient care and bring advanced therapies closer to the communities we serve.”
Dr. Mohamed Abuhaleeqa, Consultant in Hematology and Bone Marrow Transplant and Chair of Academic Affairs at Yas Clinic, added that, “Through this strategic alliance, we are building a robust ecosystem of clinical learning, scientific exchange, and translational research that will accelerate the development of advanced cellular therapies across the region.”
